Inventor
LIMBERG ANJA
CH39 patents
⚠️ This page may combine multiple inventors who share the name “LIMBERG ANJA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
28 patentsUS7208491B2Apr 24, 2007
N-monoacylated o-phenylenediamines
HOFFMANN LA ROCHE19 citations92
US7098241B2Aug 29, 2006
Thiophene hydroxamic acid derivatives
HOFFMANN LA ROCHE27 citations92
US7462639B2Dec 9, 2008
Aminopyrazole derivatives
HOFFMANN LA ROCHE46 citations91
US6869953B2Mar 22, 2005
N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
HOFFMANN LA ROCHE33 citations91
US10562903B2Feb 18, 2020
Bridged piperidine derivatives
HOFFMANN LA ROCHE12 citations86
US7812021B2Oct 12, 2010
Pyrrolidine aryl-ether as NK3 receptor antagonists
HOFFMANN LA ROCHE10 citations84
US6946462B2Sep 20, 2005
N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
HOFFMANN LA ROCHE14 citations83
US10730881B2Aug 4, 2020
Fused pyrimidine derivatives
HOFFMANN LA ROCHE2 citations73
US10941147B2Mar 9, 2021
Bicyclic heteroaryl derivatives
HOFFMANN LA ROCHE5 citations70
US9616053B2Apr 11, 2017
Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives
HOFFMANN LA ROCHE6 citations70
US11319314B2May 3, 2022
Phenoxytriazoles
HOFFMANN LA ROCHE1 citations62
US8012998B2Sep 6, 2011
Pyrrolidine aryl-ether as NK-3 receptor antagonists
HOFFMANN LA ROCHE4 citations62
US7396944B2Jul 8, 2008
Thiophene derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE3 citations62
US10899766B2Jan 26, 2021
Bridged piperidine derivatives
HOFFMANN LA ROCHE1 citations60
US10604517B2Mar 31, 2020
Bridged piperidine derivatives
HOFFMANN LA ROCHE1 citations60
US10385050B2Aug 20, 2019
Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives
HOFFMANN LA ROCHE0 citations52
US10112938B2Oct 30, 2018
Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives
HOFFMANN LA ROCHE1 citations52
US7638553B2Dec 29, 2009
Hydroxamates, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE0 citations51
US7501451B2Mar 10, 2009
Mono-acylated o-phenylendiamines derivatives
HOFFMANN LA ROCHE0 citations51
US7423060B2Sep 9, 2008
Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors
HOFFMANN LA ROCHE1 citations51
US7173060B2Feb 6, 2007
Oxime derivatives and their use as pharmaceutically active agents
HOFFMANN LA ROCHE0 citations51
US7071219B2Jul 4, 2006
Mono-acylated o-phenylendiamines derivatives
HOFFMANN LA ROCHE0 citations51
US7285569B2Oct 23, 2007
Tricycles, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE0 citations49
US9221816B2Dec 29, 2015
2-oxo-2,3-dihydro-indoles for the treatment of CNS disorders
HOFFMANN LA ROCHE1 citations48
US10875854B2Dec 29, 2020
Triazolopyridines
HOFFMANN LA ROCHE0 citations42
US10669276B2Jun 2, 2020
Fused pyrimidine derivatives
HOFFMANN LA ROCHE0 citations41
US7098247B2Aug 29, 2006
Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives
HOFFMANN LA ROCHE0 citations41
US10647721B2May 12, 2020
Bicyclic heteroaryl derivatives
HOFFMANN LA ROCHE0 citations40
NOVARTIS AG
3 patentsUS6043372AMar 28, 2000
Intermediates in the process for preparing epothilones
NOVARTIS AG98 citations97
US5969145AOct 19, 1999
Process for the production of epothilones and intermediate products within the process
NOVARTIS AG120 citations97
US6156905ADec 5, 2000
Deoxy epothilones and intermediates utilized in the process for preparing epothilones
NOVARTIS AG56 citations94